Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CDC25A | P30304 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | AURKA | O14965 | 1/20 | 0.32 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | S100A4 | P26447 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24726902 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TSHRTP53TDP1CDC25A | |
| SCHEMBL7152778 | 0.81 | ALDH1A1 (0.45) | ALDH1A1TSHRTP53TDP1CDC25B | |
| SCHEMBL9068235 | 0.71 | TSHR (0.47) | ALDH1A1TSHRTP53TDP1CDC25A | |
| SCHEMBL23865665 | 0.70 | — | — | |
| SCHEMBL21140993 | 0.70 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL3382872 | 0.69 | — | — | |
| SCHEMBL24042745 | 0.69 | MAPT (0.34) | ALDH1A1 | |
| SCHEMBL24042758 | 0.69 | KDM4E (0.36) | ACHE | |
| SCHEMBL21726021 | 0.69 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL22113017 | 0.68 | KMT2A (0.50) | ALDH1A1TSHRTP53TDP1CDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109749000-A | Low temperature curable addition polymers from vinyl aryl cyclobutene-containing monomers and methods for making the same | 罗门哈斯电子材料有限责任公司 | 2019-05-14 | — | — | CN | disclosed |
| EP-3480223-A1 | LOW TEMPERATURE CURABLE ADDITION POLYMERS FROM VINYL ARYLCYCLOBUTENE-CONTAINING MONOMERS AND METHODS FOR MAKING THE SAME | Rohm and Haas Electronic Materials LLC (US) | 2019-05-08 | — | — | EP | disclosed |
| US-20190127506-A1 | LOW TEMPERATURE CURABLE ADDITION POLYMERS FROM VINYL ARYLCYCLOBUTENE-CONTAINING MONOMERS AND METHODS FOR MAKING THE SAME | ROHM & HAAS ELECT MAT (US) | 2019-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190127506-A1 | LOW TEMPERATURE CURABLE ADDITION POLYMERS FROM VINYL ARYLCYCLOBUTENE-CONTAINING MONOMERS AND METHODS FOR MAKING THE SAME | NOD2, CARM1, ACMSD | ALDH1A1 2993/4885TSHR 4704/4885TP53 4724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.